| Primary |
| Product Used For Unknown Indication |
53.7% |
| Urinary Tract Infection |
5.0% |
| Bronchitis |
4.1% |
| Chronic Obstructive Pulmonary Disease |
3.3% |
| Infection |
3.3% |
| Pneumonia |
3.3% |
| Type 2 Diabetes Mellitus |
3.3% |
| Drug Use For Unknown Indication |
2.5% |
| Necrotising Fasciitis |
2.5% |
| Respiratory Tract Infection |
2.5% |
| Acute Bronchitis |
1.7% |
| Acute Cystitis |
1.7% |
| Arthritis Bacterial |
1.7% |
| Atrial Fibrillation |
1.7% |
| Bacterial Infection |
1.7% |
| Bronchopneumonia |
1.7% |
| Cough |
1.7% |
| Gout |
1.7% |
| Hemorrhagic Cystitis |
1.7% |
| Hip Arthroplasty |
1.7% |
|
| Urticaria |
17.2% |
| Vomiting |
8.6% |
| Erythema |
6.9% |
| Tendonitis |
6.9% |
| Hypoglycaemia |
5.2% |
| Pruritus |
5.2% |
| Tendon Pain |
5.2% |
| Acute Generalised Exanthematous Pustulosis |
3.4% |
| Blood Creatinine Increased |
3.4% |
| Convulsion |
3.4% |
| Drug-induced Liver Injury |
3.4% |
| Epilepsy |
3.4% |
| Lip Oedema |
3.4% |
| Neutropenia |
3.4% |
| Rash |
3.4% |
| Rash Pruritic |
3.4% |
| Renal Failure Acute |
3.4% |
| Renal Failure Chronic |
3.4% |
| Respiratory Tract Infection |
3.4% |
| Skin Exfoliation |
3.4% |
|
| Secondary |
| Product Used For Unknown Indication |
30.0% |
| Pneumonia |
12.2% |
| Breast Cancer |
5.6% |
| Pneumonia Aspiration |
5.6% |
| Lower Respiratory Tract Infection |
4.4% |
| Urinary Tract Infection |
4.4% |
| Urosepsis |
4.4% |
| Chronic Obstructive Pulmonary Disease |
3.3% |
| Pneumonitis |
3.3% |
| Renal Failure Acute |
3.3% |
| Respiratory Failure |
3.3% |
| Angina Unstable |
2.2% |
| Anticoagulant Therapy |
2.2% |
| Arthritis Bacterial |
2.2% |
| Cardiomegaly |
2.2% |
| Dental Operation |
2.2% |
| Essential Hypertension |
2.2% |
| Gastrointestinal Motility Disorder |
2.2% |
| Polyuria |
2.2% |
| Pseudomonas Infection |
2.2% |
|
| Urosepsis |
14.8% |
| Clostridium Difficile Infection |
7.4% |
| Gastrointestinal Hypermotility |
7.4% |
| Tendonitis |
7.4% |
| Urticaria |
7.4% |
| Headache |
3.7% |
| Hepatitis Acute |
3.7% |
| Oedema Peripheral |
3.7% |
| Pleural Effusion |
3.7% |
| Pneumonia |
3.7% |
| Pseudolymphoma |
3.7% |
| Sepsis |
3.7% |
| Thrombotic Microangiopathy |
3.7% |
| Treatment Failure |
3.7% |
| Tryptase Increased |
3.7% |
| Tuberculosis Of Central Nervous System |
3.7% |
| Tubulointerstitial Nephritis |
3.7% |
| Upper Gastrointestinal Haemorrhage |
3.7% |
| Vomiting |
3.7% |
| White Blood Cell Count Increased |
3.7% |
|
| Concomitant |
| Plasma Cell Myeloma |
34.2% |
| Chronic Lymphocytic Leukaemia |
7.9% |
| Drug Use For Unknown Indication |
7.9% |
| Chronic Obstructive Pulmonary Disease |
5.3% |
| Myelodysplastic Syndrome |
5.3% |
| Acute Lymphocytic Leukaemia |
2.6% |
| Acute Myeloid Leukaemia |
2.6% |
| Anal Inflammation |
2.6% |
| Bordetella Infection |
2.6% |
| Chronic Myeloid Leukaemia |
2.6% |
| Febrile Neutropenia |
2.6% |
| Histiocytosis |
2.6% |
| Hodgkin's Disease |
2.6% |
| Hyperuricaemia |
2.6% |
| Immunodeficiency Common Variable |
2.6% |
| Lipodystrophy Acquired |
2.6% |
| Mantle Cell Lymphoma |
2.6% |
| Myasthenia Gravis |
2.6% |
| Neuropathic Pain |
2.6% |
| Peripheral T-cell Lymphoma Unspecified |
2.6% |
|
| Pyrexia |
11.1% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
7.4% |
| Dyspnoea |
7.4% |
| Respiratory Failure |
7.4% |
| Tachycardia |
7.4% |
| Thrombocytopenia |
7.4% |
| Anxiety |
3.7% |
| Blood Calcium Increased |
3.7% |
| Contusion |
3.7% |
| Dehydration |
3.7% |
| Drug Ineffective |
3.7% |
| Endocarditis |
3.7% |
| Epistaxis |
3.7% |
| Full Blood Count Decreased |
3.7% |
| Haemoglobin Decreased |
3.7% |
| Heart Rate Decreased |
3.7% |
| Infection |
3.7% |
| Insomnia |
3.7% |
| Lethargy |
3.7% |
| Neutrophil Count Decreased |
3.7% |
|
